Asthma Link Effectiveness Trial
Launched by UNIVERSITY OF MASSACHUSETTS, WORCESTER · Apr 23, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Asthma Link Effectiveness Trial is a research study designed to see how well a school-based asthma therapy program called Asthma Link works for children aged 5 to 14 who have asthma that isn’t well controlled. This program will be compared to an educational workbook about asthma. The goal is to find out which method helps improve asthma symptoms better for these children.
To participate, children must be between 5 and 14 years old, currently taking a daily inhaled asthma medication, and have had some issues controlling their asthma in the past year. This could include needing oral steroids, a hospital visit, or having trouble remembering to take their medication. Parents or guardians must also be involved and should be able to communicate in English or Spanish. Participants will receive support from the program and may be asked to fill out questionnaires about their asthma symptoms. This trial is currently recruiting participants, so there is an opportunity for families to get involved and help improve asthma care for children.
Gender
ALL
Eligibility criteria
- STUDY INCLUSION/EXCLUSION CRITERIA:
- Child Inclusion Criteria:
- • Meet the eligibility criteria for Asthma Link (as described below)
- • Enrolled in Asthma Link (if randomized to the Asthma Link Condition)
- • Able and willing to provide informed assent
- Child Exclusion Criteria:
- • Unable or unwilling to provide informed assent
- • Developmental delay that would prevent study participation.
- Parent Inclusion Criteria:
- • Parent/guardian to patient
- • 18 years or older
- • Able to understand and communicate in English or Spanish
- • Able and willing to provide informed consent.
- Child eligibility for children enrolled in Asthma Link:
- • children aged 5-14 years (enrolled in grade K-8)
- • prescribed daily inhaled corticosteroid (ICS) for asthma
- • Asthma Control Test (ACT) score ≤19 OR 1 or more of ANY of following in the past 1 year: course of oral steroids, hospitalization, Emergency Department visit, sick visit for asthma
- • parent/child report of poor ICS adherence on adherence checklist- i.e. child or parent says "Yes" when provider asks if they have difficulty remembering to take their medication or if they regularly take medication holidays or breaks
- • able and willing to assent
- • parental permission
- • English or Spanish speaking
About University Of Massachusetts, Worcester
The University of Massachusetts Worcester is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the university integrates cutting-edge scientific inquiry with a commitment to improving patient outcomes. Its collaborative approach engages a diverse range of experts, fostering interdisciplinary research that addresses pressing health challenges. With a focus on ethical standards and regulatory compliance, the University of Massachusetts Worcester plays a pivotal role in translating scientific discoveries into practical applications that enhance medical practice and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Worcester, Massachusetts, United States
Patients applied
Trial Officials
Michelle Trivedi, MD
Principal Investigator
UMass Chan Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported